About this Journal Submit a Manuscript Table of Contents
Anemia
Volume 2012 (2012), Article ID 659303, 7 pages
http://dx.doi.org/10.1155/2012/659303
Research Article

Eryptotic Phenotype in Chronic Myeloid Leukemia: Contribution of Neutrophilic Cathepsin G

1Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Kharghar, Navi Mumbai 410 210, India
2Department of Medical Microbiology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang 43400, Malaysia
3Department of Medical Oncology, Jaslok Hospital and Research Centre, Mumbai 400 026, India

Received 27 August 2011; Revised 16 November 2011; Accepted 22 December 2011

Academic Editor: Eitan Fibach

Copyright © 2012 Rukmini Govekar et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. B. Segel, M. W. Halterman, and M. A. Lichtman, “The paradox of the neutrophil's role in tissue injury,” Journal of Leukocyte Biology, vol. 89, no. 3, pp. 359–372, 2011. View at Publisher · View at Google Scholar · View at PubMed
  2. A. Santos-Silva, E. Molnar Bayer Castro, N. Almeida Teixeira, F. Carvalho Guerra, and A. Quintanilha, “Altered erythrocyte membrane band 3 profile as a marker in patients at risk for cardiovascular disease,” Atherosclerosis, vol. 116, no. 2, pp. 199–209, 1995. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Santos-Silva, I. Rebelo, E. Castro et al., “Erythrocyte damage and leukocyte activation in ischemic stroke,” Clinica Chimica Acta, vol. 320, no. 1-2, pp. 29–35, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. L. Belo, I. Rebelo, E. M. B. Castro et al., “Band 3 as a marker of erythrocyte changes in pregnancy,” European Journal of Haematology, vol. 69, no. 3, pp. 145–151, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. M. M. B. Kay, S. R. Goodman, and K. Sorensen, “Senescent cell antigen is immunologically related to band 3,” Proceedings of the National Academy of Sciences of the United States of America, vol. 80, no. 6, pp. 1631–1635, 1983. View at Scopus
  6. M. M. B. Kay, “Localization of senescent cell antigen on band 3,” Proceedings of the National Academy of Sciences of the United States of America, vol. 81, no. 18, pp. 5753–5757, 1984. View at Scopus
  7. A. Santos-Silva, E. M. B. Castro, N. A. Teixeira, F. C. Guerra, and A. Quintanilha, “Erythrocyte membrane band 3 profile imposed by cellular aging, by activated neutrophils and by neutrophilic elastase,” Clinica Chimica Acta, vol. 275, no. 2, pp. 185–196, 1998. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Bykowska, M. Duk, G. Kusnierz-Alejska, M. Kopec, and E. Lisowska, “Degradation of human erythrocytre surface components by human neutrophil elastase and cathepsin G: preferential digestion of glycophorins,” British Journal of Haematology, vol. 84, no. 4, pp. 736–742, 1993. View at Scopus
  9. K. Bykowska, M. Duk, G. Kusnierz-Alejska et al., “Degradation of glycophorin A of human erythrocytes in patients with myelo- or lymphoproliferative disorders: possible role of neutrophil proteases,” British Journal of Haematology, vol. 96, no. 3, pp. 514–520, 1997. View at Publisher · View at Google Scholar
  10. A. Kumar and C. M. Gupta, “Red cell membrane abnormalities in chronic myeloid leukaemia,” Nature, vol. 303, no. 5918, pp. 632–633, 1983. View at Scopus
  11. M. Kundu, J. Basu, and P. Chakrabarti, “Chronic myelogenous leukemia: alterations in red cell membrane band 3 and increased IgG binding,” Indian Journal of Biochemistry and Biophysics, vol. 27, no. 6, pp. 456–459, 1990. View at Scopus
  12. M. M. B. Kay, N. Flowers, J. Goodman, and G. Bosman, “Alteration in membrane protein band 3 associated with accelerated erythrocyte aging,” Proceedings of the National Academy of Sciences of the United States of America, vol. 86, no. 15, pp. 5834–5838, 1989. View at Scopus
  13. P. Kubes, R. Smith, M. D. Grisham, and D. N. Granger, “Neutrophil-mediated proteolysis. Differential roles for cathepsin G and elastase,” Inflammation, vol. 17, no. 3, pp. 321–332, 1993. View at Publisher · View at Google Scholar · View at Scopus
  14. J. T. Dodge, C. Mitchell, and D. J. Hanahan, “The preparation and chemical characteristics of hemoglobin-free ghosts of human erythrocytes,” Archives of Biochemistry and Biophysics, vol. 100, no. 1, pp. 119–130, 1963. View at Scopus
  15. G. L. Peterson, “A simplification of the protein assay method of Lowry et al. Which is more generally applicable,” Analytical Biochemistry, vol. 83, no. 2, pp. 346–356, 1977. View at Scopus
  16. H. Towbin, T. Staehelin, and J. Gordon, “Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications,” Proceedings of the National Academy of Sciences of the United States of America, vol. 76, no. 9, pp. 4350–4354, 1979. View at Scopus
  17. R. B. Govekar, A. K. D'Cruz, K. A. Pathak et al., “Proteomic profiling of cancer of the gingivo-buccal complex: identification of new differentially expressed markers,” Proteomics—Clinical Applications, vol. 3, no. 12, pp. 1451–1462, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. P. Arese, F. Turrini, and E. Schwarzer, “Band 3/complement-mediated recognition and removal of normally senescent and pathological human erythrocytes,” Cellular Physiology and Biochemistry, vol. 16, no. 4–6, pp. 133–146, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. G. Tarone, N. Hamasaki, M. Fukuda, and V. T. Marchesi, “Proteolytic degradation of human erythrocyte band 3 by membrane-associated protease activity,” Journal of Membrane Biology, vol. 48, no. 1, pp. 1–12, 1979. View at Scopus
  20. D. Mandal, P. K. Moitra, S. Saha, and J. Basu, “Caspase 3 regulates phosphatidylserine externalization and phagocytosis of oxidatively stressed erythrocytes,” FEBS Letters, vol. 513, no. 2-3, pp. 184–188, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. D. Mandal, V. Baudin-Creuza, A. Bhattacharyya et al., “Caspase 3-mediated proteolysis of the N-terminal cytoplasmic domain of the human erythroid anion exchanger 1 (band 3),” Journal of Biological Chemistry, vol. 278, no. 52, pp. 52551–52558, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. N. Balasubramanian, S. H. Advani, and S. M. Zingde, “Protein kinase C isoforms in normal and chronic myeloid leukemic neutrophils. Distinct signal for PKC α by immunodetection on PVDF membrane, decreased expression of PKC α and increased expression of PKC δ in leukemic neutrophils,” Leukemia Research, vol. 22, no. 7, pp. 597–604, 1998. View at Publisher · View at Google Scholar · View at Scopus
  23. R. B. Govekar and S. M. Zingde, “Protein kinase C isoforms in human erythrocytes,” Annals of Hematology, vol. 80, no. 9, pp. 531–534, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. N. Bangalore and J. Travis, “Comparison of properties of membrane bound versus soluble forms of human leukocytic elastase and cathepsin G,” Biological Chemistry Hoppe-Seyler, vol. 375, no. 10, pp. 659–666, 1994. View at Scopus
  25. I. I. Smirnov, V. N. Levin, and N. P. Zdiumaeva, “Protein adsorption on erythrocytic membranes and its effect on erythrocyte rheology in athletes during competition exercise,” Fiziologiia cheloveka, vol. 30, no. 3, pp. 126–132, 2004. View at Scopus
  26. M. Takeda-Ezaki and K. Yamamoto, “Isolation and biochemical characterization of procathepsin E from human erythrocyte membranes,” Archives of Biochemistry and Biophysics, vol. 304, no. 2, pp. 352–358, 1993. View at Publisher · View at Google Scholar · View at Scopus
  27. L. Lorand, O. J. Bjerrum, and M. Hawkins, “Degradation of transmembrane proteins in Ca2+ -enriched human erythrocytes. An immunochemical study,” Journal of Biological Chemistry, vol. 258, no. 8, pp. 5300–5305, 1983. View at Scopus
  28. M. M. B. Kay and J. R. Goodman, “IgG antibodies do not bind to band 3 in intact erythrocytes; enzymatic treatment of cells is required for IgG binding,” Biomedica Biochimica Acta, vol. 43, no. 6, pp. 841–846, 1984. View at Scopus